Evaluation of Hormonal Changes in Women on Erlotinib Therapy
Patients undergo a dermatology evaluation and complete the Polycystic Ovarian Syndrome
(PCOS) research study questionnaire once. Blood samples are collected after an overnight
fast. Samples are analyzed for circulating levels of total and bioavailable testosterone,
dehydroepiandrosterone sulfate, and sex hormone binding globulin. Serum luteinizing hormone,
follicle stimulating hormone, fasting glucose, and insulin levels are also assessed.
Observational Model: Case-Only, Time Perspective: Prospective
Presence of hyperandrogenemia
We will determine if hyperandrogenemia is present in women with nonsmall cell lung cancer who are taking erlotinib.
One approximate 30 minute visit
Jyoti D. Patel, MD
United States: Institutional Review Board
|Northwestern University, Northwestern Medical Faculty Foundation||Chicago, Illinois 60611-3013|